Conference
15-16.09.22

Reverse Engineering
of Digital Measures
  
A conference on patient-centric digital evidence.

by ETH Zurich and FNIH. 

Zürich, Switzerland
15-16 September 2022
ETH Zurich, HG Main Building 
imageCarousel.imageformat.lightbox.jpg

Programme 

2 Days 4 Use Cases
Go to Agenda for detailed information 


Thu.15.09.2022 - 11:00-22.00 CET 

Qualification of New Digital Evidence

Use Case 1: MOBILISE-D:

Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement

Use Case 2: IDEA FAST:

Identifying digital endpoints to assess fatigue, sleep and activities in daily living in neurodegenerative disorders and immune-mediated inflammatory diseases

Fri. 16.09.2022 - 11:00-22:00 CET

From Efficacy to Effectiveness

Use Case 3: Roche DHTs for SMA:

Digital Health Technologies to better measure outcomes in Spinal Muscular Atrophy


Use Case 4: SCZ:

The Accelerating Medicines Partnership® Program – Schizophrenia (AMP® SCZ)

* If you can't join the conference you can watch the live stream for participation.

 

About the conference

What is it about?

In February 2020, the FNIH Biomarkers Consortium hosted a conference to examine progress in, and establish a path forward for, incorporating remote digital monitoring into clinical evidence generation. This highly interactive, collaborative meeting crystalised and catalysed much of the recent progress we have seen in digital measurement of health. Nearly three years later, we are launching the next iteration of the meeting, to be hosted by the ETH in Zurich, Switzerland. One of the key achievements was an increased awareness of how patient centricity is critical for success in developing new digital measures.

Meeting Overview and Aims

Co-organised with the FNIH Biomarkers Consortium, the meeting is titled “Reverse Engineering of Digital Measures.” It will build on the success of the first meeting, sharing the experiences of four extended case studies and examining progress, opportunities and challenges. The interactive case studies will involve regulators, industry, patients and innovators and emphasise how patient centricity is shaping the development and validation of new evidence across settings including regulatory interactions, reimbursement and product development.

Over two full afternoons, we will explore how human-centered, holistic, evidence-based science is being put into practice and examine how this is shaping regulatory and payer interactions, patient and human engagement, product development and embedding of digital measures into decision making throughout care delivery.

 

Jörg Goldhahn and Steve Hoffmann


The meeting will be in presence, following current Swiss hygiene guidelines, with live streaming. We are really hoping as many of you as possible will be able to attend, we want to continue the robust discussion and exchange of ideas started in the first meeting.
 

Human-centric

Patients, participants, caregiver are the ultimate stakeholders for our work — we all talk about engaging them, how far are we from achieving that? What are best practices and shining examples (or failures)?

Holistic

Integration across health services, telemedicine, etc, how is our understanding of disease changing? Efforts at breaking down silos across treatment and data sources. Examples of integrated care, personalized care, predictive/preventative interventions, etc.

Evidence-based

Demonstrating fit for purpose (regulators), treatment value (insurers) and business value (pharma, startups)

Information and Papers from the first meeting, hosted by the FNIH in 2020:

• Meeting Overview including agenda andsession recordings
• Remote digital monitoring in clinical trials in the time of COVID-19. 
   Goldsack JC, et al. Nature Reviews Drug Discovery (2020)
• Remote Digital Monitoring for Medical Product Development.
   Izmailova EA, et al. Clin Transl Sci (2020)

 
Participants

150

Use Cases

4

Sessions

12

Speakers

24

Speakers 

download_edited_edited.png

Steve Hoffmann

FNIH 

Elena Izmailova  Koneksa Health 

Jörg Goldhahn

ETH

Ursula Costa

Basel Area Swiss

Foteini Orfaniotou

Roche

Thanneer Mailai Perumal Roche

Francesca Cormack

Cambridge Cognition

Wojtek Piwko

Takeda 

Ieuan Clay

VivoSense

Beatrix Vereijken

NTNU

Justin Baker

Partners

David Nobbs

Roche

Arne Müller

Novartis

Lada Leyens 

Roche

Thorsten Vetter

EMA

John Varaklis

PHYSIQ

Dana Connors

FNIH

John Torous

Harvard

Medical School

 Christopher Bull 

Newcastle University

Tova Gur Arieh

Nitzan Association

Clemens Becker

Robert Bosch Krankenhaus

Alison Keogh

Trinity College Dublin

Wim Dartee

Novartis

Andrea Cereatti

Politecnico di Torino

Committees
General Co-Chairs
Jörg Goldhahn, ETH
Steve Hoffmann, FNIH


Technical Programme Co-Chairs 
Ieuan Clay, Vivosense
Laurenz Baltzer, ETH
 

Steering Committee

Jörg Goldhahn, ETH
Steve Hoffmann, FNIH
Dana Connors, FNIH
Thorsten Vetter, EMA
Peter Groenen, Idorsia
John Varaklis, PhysIQ


Organizing Committee 
Alexandra Bündner, ETH 
Anja Finkel, ETH 
Anja Rüdisüli, ETH

 
 
 

Sponsors

Venue Reverse Engineering of Digital Measures Conference 15-16.09.22